Literature DB >> 14623268

Acute effects of PYY3-36 on food intake and hypothalamic neuropeptide expression in the mouse.

B G Challis1, S B Pinnock, A P Coll, R N Carter, S L Dickson, S O'Rahilly.   

Abstract

It has recently been suggested that gut-derived PYY(3-36) may be involved in the central mediation of post-prandial satiety signals. We have examined the acute effects of peripherally administered PYY(3-36) on food intake and hypothalamic gene expression of neuropeptides in mice. A single intraperitoneal injection of PYY(3-36) to mice that had been fasted for 24h resulted in a highly significant reduction in food intake at 6 and 24h post-injection but not at 48h. However, in freely fed mice, food intake was unaltered by PYY(3-36) administration. In the arcuate nucleus POMC mRNA expression was significantly elevated at 6h and remained elevated at 24h following PYY(3-36) injection. By contrast NPY mRNA expression in the arcuate nucleus was suppressed at 6h but not at 24h post-injection. In the lateral hypothalamus there were no differences in MCH mRNA expression at either time point. In conclusion, peripherally administered PYY(3-36) has a suppressive effect on food intake that is more prominent in recently fasted mice and lasts up to 24 h. This is associated with a short-lived suppression of NPY mRNA, a longer lasting increase in POMC mRNA but no change in MCH mRNA expression.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14623268     DOI: 10.1016/j.bbrc.2003.10.089

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  48 in total

1.  Central and peripheral administration of secretin inhibits food intake in mice through the activation of the melanocortin system.

Authors:  Carrie Yuen Yee Cheng; Jessica Yan Shuen Chu; Billy Kwok Chong Chow
Journal:  Neuropsychopharmacology       Date:  2010-10-06       Impact factor: 7.853

Review 2.  Gut hormones: the future of obesity treatment?

Authors:  Anne K McGavigan; Kevin G Murphy
Journal:  Br J Clin Pharmacol       Date:  2012-12       Impact factor: 4.335

Review 3.  Role of gastrointestinal hormones in feeding behavior and obesity treatment.

Authors:  Timothy Sean Kairupan; Haruka Amitani; Kai-Chun Cheng; Joshua Runtuwene; Akihiro Asakawa; Akio Inui
Journal:  J Gastroenterol       Date:  2015-09-07       Impact factor: 7.527

Review 4.  Gut hormones ghrelin, PYY, and GLP-1 in the regulation of energy balance [corrected] and metabolism.

Authors:  Diego Perez-Tilve; Ruben Nogueiras; Federico Mallo; Stephen C Benoit; Matthias Tschoep
Journal:  Endocrine       Date:  2006-02       Impact factor: 3.633

Review 5.  Gut hormones as potential new targets for appetite regulation and the treatment of obesity.

Authors:  Benjamin C T Field; Alison M Wren; Dunstan Cooke; Stephen R Bloom
Journal:  Drugs       Date:  2008       Impact factor: 9.546

Review 6.  Hungry for life: How the arcuate nucleus and neuropeptide Y may play a critical role in mediating the benefits of calorie restriction.

Authors:  Robin K Minor; Joy W Chang; Rafael de Cabo
Journal:  Mol Cell Endocrinol       Date:  2008-11-11       Impact factor: 4.102

7.  Peptide YY levels are decreased by fasting and elevated following caloric intake but are not regulated by leptin.

Authors:  J L Chan; V Stoyneva; T Kelesidis; P Raciti; C S Mantzoros
Journal:  Diabetologia       Date:  2005-12-09       Impact factor: 10.122

Review 8.  Obesity treatment: novel peripheral targets.

Authors:  Benjamin C T Field; Owais B Chaudhri; Stephen R Bloom
Journal:  Br J Clin Pharmacol       Date:  2009-12       Impact factor: 4.335

9.  Mice lacking pro-opiomelanocortin are sensitive to high-fat feeding but respond normally to the acute anorectic effects of peptide-YY(3-36).

Authors:  B G Challis; A P Coll; G S H Yeo; S B Pinnock; S L Dickson; R R Thresher; J Dixon; D Zahn; J J Rochford; A White; R L Oliver; G Millington; S A Aparicio; W H Colledge; A P Russ; M B Carlton; S O'Rahilly
Journal:  Proc Natl Acad Sci U S A       Date:  2004-03-15       Impact factor: 11.205

10.  Anorexia induction by the trichothecene deoxynivalenol (vomitoxin) is mediated by the release of the gut satiety hormone peptide YY.

Authors:  Brenna M Flannery; Erica S Clark; James J Pestka
Journal:  Toxicol Sci       Date:  2012-08-17       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.